Department of Radiology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
Department of Pulmonary and Critical Care Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
Lancet Respir Med. 2020 Jul;8(7):726-737. doi: 10.1016/S2213-2600(20)30168-5.
The term interstitial lung abnormalities refers to specific CT findings that are potentially compatible with interstitial lung disease in patients without clinical suspicion of the disease. Interstitial lung abnormalities are increasingly recognised as a common feature on CT of the lung in older individuals, occurring in 4-9% of smokers and 2-7% of non-smokers. Identification of interstitial lung abnormalities will increase with implementation of lung cancer screening, along with increased use of CT for other diagnostic purposes. These abnormalities are associated with radiological progression, increased mortality, and the risk of complications from medical interventions, such as chemotherapy and surgery. Management requires distinguishing interstitial lung abnormalities that represent clinically significant interstitial lung disease from those that are subclinical. In particular, it is important to identify the subpleural fibrotic subtype, which is more likely to progress and to be associated with mortality. This multidisciplinary Position Paper by the Fleischner Society addresses important issues regarding interstitial lung abnormalities, including standardisation of the definition and terminology; predisposing risk factors; clinical outcomes; options for initial evaluation, monitoring, and management; the role of quantitative evaluation; and future research needs.
术语“间质性肺异常”是指在没有疾病临床怀疑的情况下,特定 CT 表现可能与间质性肺疾病相符。间质性肺异常越来越被认为是老年人肺部 CT 的常见特征,在吸烟者中发生率为 4-9%,在不吸烟者中发生率为 2-7%。随着肺癌筛查的实施以及 CT 在其他诊断目的中的应用增加,间质性肺异常的识别率将会提高。这些异常与影像学进展、死亡率增加以及与医疗干预(如化疗和手术)相关的并发症风险相关。管理需要区分代表有临床意义的间质性肺疾病的间质性肺异常和无症状的间质性肺异常。特别是,识别出更有可能进展并与死亡率相关的胸膜下纤维化亚型非常重要。Fleischner 学会的这份多学科立场文件涉及间质性肺异常的重要问题,包括定义和术语的标准化;易患风险因素;临床结局;初始评估、监测和管理的选择;定量评估的作用;以及未来的研究需求。